Research Nester released a report titled “Integrative Medicines (IM) Market: Global Demand Analysis & Opportunity Outlook 2035” which delivers detailed overview of the global integrative medicines (IM) market in terms of market segmentation by intervention, sales channel, and by region.
Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.
The global integrative medicines (IM) market is projected to grow with a high CAGR during the forecast period, i.e., 2023-2035 on account of the increasing elderly population and rising prevalence of chronic diseases. In addition, rising investment to develop alternative treatment methodologies and growing awareness about mental health are also expected to drive market growth in the future.
The market is segmented by intervention into botanicals, body healing, mind healing, external energy, and sensory healing. Among these segments, the botanicals segment is anticipated to hold the largest share during the forecast period attributing to the increasing adoption of natural remedies such as Ayurveda and homeopathy worldwide. The segment is also estimated to observe growth owing to the worldwide recognition for its pain free, needle-less and continuous process.
On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, out of which, the integrative medicines (IM) market in the Middle East & Africa is projected to grow at the highest CAGR throughout the forecast period owing to the rising awareness regarding IM. Moreover, the market in Europe is predicted to hold the largest share, which can be attributed to the presence of leading integrative medicine providers in the region.
Increasing Ageing Population and Growing Adoption of Natural Therapies to Drive Market Growth
According to the data collected from……………
